Healthcare

Eastern Shore Cosmetic Surgery Expands Services with Personalized Hormone Replacement Therapy

Eastern Shore Cosmetic Surgery Expands Services with Personalized Hormone Replacement Therapy

Eastern Shore Cosmetic Surgery introduces bioidentical hormone replacement therapy (BHRT), offering a personalized, natural approach to addressing hormone imbalances for both women and men. The new service aims to provide comprehensive wellness solutions tailored to individual patient needs.

May 7, 2025
Masseter Botox: Providing Relief for Jaw Pain While Reshaping Facial Contours

Masseter Botox: Providing Relief for Jaw Pain While Reshaping Facial Contours

A new medical procedure using Botox injections in the masseter muscle offers significant relief for patients with TMJ and teeth grinding, while also providing potential aesthetic benefits. The treatment presents both functional and cosmetic advantages, though long-term effects remain a topic of professional discussion.

May 7, 2025
Macleod Optometry Brings Advanced Eye Care and Designer Eyewear to Calgary's Southwest

Macleod Optometry Brings Advanced Eye Care and Designer Eyewear to Calgary's Southwest

A new optometry clinic in Calgary offers comprehensive eye care services with cutting-edge technology, personalized treatments, and a stylish eyewear selection, focusing on patient-centered healthcare for all ages.

May 7, 2025
Dogs Playing for Life Reaches 400th Shelter, Enhances Canine Welfare in Washington DC

Dogs Playing for Life Reaches 400th Shelter, Enhances Canine Welfare in Washington DC

Dogs Playing for Life partners with Brandywine Valley SPCA to introduce playgroup training at their Washington DC campus, marking a milestone in improving shelter dog quality of life and increasing adoption rates.

May 6, 2025
Kairos Pharma to Showcase Oncology Research at D. Boral Capital Global Conference

Kairos Pharma to Showcase Oncology Research at D. Boral Capital Global Conference

Kairos Pharma will participate in the D. Boral Capital Inaugural Global Conference, offering investors insights into its innovative cancer therapeutic research, focusing on overcoming drug resistance with its lead candidate ENV105.

May 6, 2025
University of Utah Researchers Develop AI Tool to Predict Disease Onset Years in Advance

University of Utah Researchers Develop AI Tool to Predict Disease Onset Years in Advance

Researchers have created RiskPath, an open-source AI platform capable of forecasting long-term health conditions before symptoms emerge, potentially revolutionizing preventive healthcare approaches.

May 6, 2025
HeartBeam Expands Patent Portfolio with Innovative Cardiac Monitoring Technologies

HeartBeam Expands Patent Portfolio with Innovative Cardiac Monitoring Technologies

Medical technology company HeartBeam adds two new U.S. patents to its intellectual property collection, enhancing its capabilities in portable cardiac monitoring and arrhythmia detection technology.

May 6, 2025
Women with Autoimmune Diseases Face Higher Cardiovascular Death Risk

Women with Autoimmune Diseases Face Higher Cardiovascular Death Risk

A new study reveals that women with common autoimmune diseases like rheumatoid arthritis, lupus, and systemic sclerosis experience significantly higher cardiovascular disease-related mortality rates compared to men, highlighting critical gender disparities in health outcomes.

May 6, 2025
Study Reveals Pregnancy-Related Genes Contribute to Worse Lung Cancer Outcomes in Women

Study Reveals Pregnancy-Related Genes Contribute to Worse Lung Cancer Outcomes in Women

A new study from Memorial Sloan Kettering Cancer Center has uncovered how certain genes associated with pregnancy may negatively impact lung cancer survival rates in women, providing insights into potential future immune therapy developments.

May 6, 2025
Pacylex Pharmaceutical Explores N-myristoyltransferase Inhibitors as Potential ADC Cancer Therapies

Pacylex Pharmaceutical Explores N-myristoyltransferase Inhibitors as Potential ADC Cancer Therapies

Pacylex Pharmaceuticals is presenting innovative research on N-myristoyltransferase (NMT) inhibitors as potential payloads for antibody drug conjugates (ADCs), highlighting promising early clinical results in cancer treatment across multiple tumor types.

May 6, 2025
Recovery Journey: One Woman's Transformation at Purpose Healing Center

Recovery Journey: One Woman's Transformation at Purpose Healing Center

Purpose Healing Center offers comprehensive, compassionate addiction and mental health treatment in Scottsdale, Arizona, demonstrating how personalized, evidence-based care can help individuals overcome significant personal challenges and rebuild their lives.

May 6, 2025
Author Dr. Kixx Goldman Offers Free Ebook Exploring Personal Resilience and Healing

Author Dr. Kixx Goldman Offers Free Ebook Exploring Personal Resilience and Healing

Dr. Kixx Goldman is making her bestselling ebook 'Speak From Your Heart And Be Heard' available for free, offering readers insights into overcoming personal challenges through eight compelling fictional stories inspired by real-life experiences.

May 6, 2025
McKinney Dental Practice Launches Website with Focus on Anxiety-Free Patient Care

McKinney Dental Practice Launches Website with Focus on Anxiety-Free Patient Care

Starlite Dental, led by Dr. Nidhi Jaiswal, introduces a new website highlighting comprehensive dental services designed to eliminate patient anxiety and provide compassionate, high-quality oral healthcare in the Dallas-Fort Worth area.

May 6, 2025
HeartBeam Expands Board with CEO Robert Eno's Appointment

HeartBeam Expands Board with CEO Robert Eno's Appointment

HeartBeam Inc. strengthens its leadership by appointing CEO Robert Eno to its Board of Directors, signaling strategic preparation for the commercial launch of its innovative 3D ECG technology.

May 5, 2025
NanoViricides to Present at D. Boral Capital Inaugural Global Conference, Highlighting Antiviral Drug Development

NanoViricides to Present at D. Boral Capital Inaugural Global Conference, Highlighting Antiviral Drug Development

NanoViricides, a clinical-stage biotech company specializing in nanomedicine-based antiviral treatments, will participate in the D. Boral Capital Inaugural Global Conference, offering investors insights into its advanced drug candidates targeting respiratory viral infections and other diseases.

May 5, 2025
Soligenix's HyBryte Shows Promising Results in CTCL Treatment, Offering New Hope for Rare Skin Cancer Patients

Soligenix's HyBryte Shows Promising Results in CTCL Treatment, Offering New Hope for Rare Skin Cancer Patients

Biotechnology company Soligenix has reported impressive interim results for HyBryte, a novel topical treatment for cutaneous T-cell lymphoma (CTCL), demonstrating a 75% response rate and potential to address a significant unmet medical need.

May 5, 2025
New Daily Planner Aims to Transform Health Habits in 10 Minutes

New Daily Planner Aims to Transform Health Habits in 10 Minutes

A husband-and-wife team launches the Health & Well-Being Journal, a science-backed daily planner designed to help individuals develop sustainable health habits with minimal time investment. The journal combines behavioral science and wellness strategies to support holistic personal well-being.

May 3, 2025
Free Ebook Offers Insights into Teen Resilience and Self-Esteem

Free Ebook Offers Insights into Teen Resilience and Self-Esteem

Dr. Barbara Becker Holstein's latest ebook, 'Conflict and a Bit of Magic', will be available as a free download, providing a narrative approach to helping young girls build self-confidence and navigate challenging life experiences.

May 3, 2025
Santa Cruz Breaks Seven-Year Sugary Drink Tax Drought, Voters Approve Public Health Measure

Santa Cruz Breaks Seven-Year Sugary Drink Tax Drought, Voters Approve Public Health Measure

Santa Cruz has become the first California city since 2018 to implement a sugary drink tax, marking a significant victory for public health advocates against the beverage industry's opposition. The two-cents-per-ounce tax is expected to generate $1.3 million annually and aims to reduce sugary drink consumption.

May 2, 2025
Patient Exodus Follows Hospital Exits from Medicare Advantage Plans

Patient Exodus Follows Hospital Exits from Medicare Advantage Plans

New data reveals that when hospitals terminate contracts with Medicare Advantage insurers, significant numbers of patients abandon their current health plans, highlighting potential systemic challenges in healthcare coverage.

May 2, 2025
Aditxt Advances ADI-100 Therapeutic Development with Leadership Update

Aditxt Advances ADI-100 Therapeutic Development with Leadership Update

Aditxt Inc. continues to develop innovative immune-modulating therapies through its ADI-100 therapeutic candidate, highlighting ongoing progress in its health innovation platform. The company's strategic approach involves collaborative research and potential expansion into multiple health domains.

May 2, 2025
Heart Failure Initiative Dramatically Increases Lifesaving Medication Use

Heart Failure Initiative Dramatically Increases Lifesaving Medication Use

A large-scale American Heart Association initiative has significantly improved the use of quadruple medical therapy for heart failure patients across U.S. hospitals, potentially reducing mortality rates and addressing treatment disparities.

May 2, 2025
BalanceRX Launches Nationwide Telehealth Platform for Active Adults Over 45

BalanceRX Launches Nationwide Telehealth Platform for Active Adults Over 45

BalanceRX introduces a telehealth service targeting adults 45 and older, addressing declining physical activity and offering personalized health strategies to support active lifestyles and overall vitality.

May 2, 2025
RCR|HUB Spotlights Kentucky Healthcare Excellence in Annual Derby Edition Magazine

RCR|HUB Spotlights Kentucky Healthcare Excellence in Annual Derby Edition Magazine

RCR|HUB's latest RCM Connections Magazine offers an in-depth exploration of Kentucky's healthcare performance, strategically timed with the Kentucky Derby to highlight the state's healthcare innovations and revenue cycle management trends.

May 2, 2025
Nonprofit Launches 5th Annual Campaign to Spotlight Pregnancy and Postpartum Psychosis

Nonprofit Launches 5th Annual Campaign to Spotlight Pregnancy and Postpartum Psychosis

Cherished Mom's Pregnancy & Postpartum Psychosis Awareness Day aims to raise critical understanding about a severe maternal mental health condition that affects 1-2 out of every 1,000 deliveries, highlighting potential risks and the importance of early intervention.

May 2, 2025
GeoVax Advances COVID-19, Cancer, and Biosecurity Vaccine Platforms Despite BARDA Contract Setback

GeoVax Advances COVID-19, Cancer, and Biosecurity Vaccine Platforms Despite BARDA Contract Setback

GeoVax Labs reports significant progress across multiple vaccine development programs, including a multi-antigen COVID-19 vaccine for immunocompromised patients, an oncology treatment for head and neck cancer, and a Mpox/smallpox vaccine addressing global biosecurity needs.

May 1, 2025
HealthLynked Enhances Healthcare Platform with Advanced Appointment Booking and Patient Review Features

HealthLynked Enhances Healthcare Platform with Advanced Appointment Booking and Patient Review Features

HealthLynked Corp. has upgraded its digital healthcare platform to improve patient access to medical providers, offering enhanced appointment booking, concierge services, and a new provider review system designed to help patients make more informed healthcare decisions.

May 1, 2025
Soligenix Advances Treatment for Rare Skin Cancer with HyBryte™ Therapy

Soligenix Advances Treatment for Rare Skin Cancer with HyBryte™ Therapy

Soligenix's HyBryte™ therapy shows promise in treating early-stage cutaneous T-cell lymphoma, potentially addressing a significant gap in rare disease treatments within a rapidly growing global market.

May 1, 2025
TransCode Therapeutics Advances RNA Cancer Therapy in Phase 1a Trial, Shows Promising Early Results

TransCode Therapeutics Advances RNA Cancer Therapy in Phase 1a Trial, Shows Promising Early Results

TransCode Therapeutics reports encouraging progress in its Phase 1a trial of TTX-MC138, an RNA-based cancer therapy targeting microRNA-10b, with initial data suggesting potential effectiveness in treating metastatic tumors.

May 1, 2025
Hippocrates Wellness Launches 'Quantum Human' Book with Nationwide Media Tour

Hippocrates Wellness Launches 'Quantum Human' Book with Nationwide Media Tour

Dr. Brian Clement's new book 'Quantum Human' promises to offer insights into progressive healthcare and wellness, backed by a comprehensive 37-city media tour. The release signals a potential shift in understanding holistic health approaches.

May 1, 2025
PreviousPage 73 of 80Next